Skip to main content
. 2019 Jan 14;2019(1):CD005431. doi: 10.1002/14651858.CD005431.pub4

Comparison 4. Systemic versus topical aminocaproic acid.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Short‐term visual acuity from 20/20 to 20/40 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
2 Risk of secondary hemorrhage 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
3 Adverse effects 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
3.1 Conjunctival corneal foreign body sensation 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 Transient punctate corneal staining 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Dizziness, nausea, vomiting 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]